nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast®)
|
Germann, I. |
|
2006 |
13 |
S1 |
p. 45-50 6 p. |
artikel |
2 |
Binding of STW 5 (Iberogast®) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors
|
Simmen, U. |
|
2006 |
13 |
S1 |
p. 51-55 5 p. |
artikel |
3 |
Editorial Board
|
|
|
2006 |
13 |
S1 |
p. CO2- 1 p. |
artikel |
4 |
Ex vivo/in vitro absorption of STW 5 (Iberogast®) and its extract components
|
Kelber, O. |
|
2006 |
13 |
S1 |
p. 107-113 7 p. |
artikel |
5 |
Functional dyspepsia – A multicausal disease and its therapy
|
Allescher, H.D. |
|
2006 |
13 |
S1 |
p. 2-11 10 p. |
artikel |
6 |
Intestinal spasmolytic effects of STW 5 (Iberogast®) and its components
|
Heinle, H. |
|
2006 |
13 |
S1 |
p. 75-79 5 p. |
artikel |
7 |
Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast®) and its components against ulcers and rebound acidity
|
Khayyal, M.T. |
|
2006 |
13 |
S1 |
p. 56-66 11 p. |
artikel |
8 |
Multitarget therapy – The future of treatment for more than just functional dyspepsia
|
Wagner, H. |
|
2006 |
13 |
S1 |
p. 122-129 8 p. |
artikel |
9 |
[No title]
|
Wagner, H. |
|
2006 |
13 |
S1 |
p. 1- 1 p. |
artikel |
10 |
Pharmaceutical prerequisites for a multi-target therapy
|
Kroll, U. |
|
2006 |
13 |
S1 |
p. 12-19 8 p. |
artikel |
11 |
Phytotherapy for functional dyspepsia: A review of the clinical evidence for the herbal preparation STW 5
|
Rösch, W. |
|
2006 |
13 |
S1 |
p. 114-121 8 p. |
artikel |
12 |
Radical scavenging and anti-inflammatory properties of STW 5 (Iberogast®) and its components
|
Schempp, H. |
|
2006 |
13 |
S1 |
p. 36-44 9 p. |
artikel |
13 |
Region-specific effects of STW 5 (Iberogast ® ) and its components in gastric fundus, corpus and antrum
|
Schemann, M. |
|
2006 |
13 |
S1 |
p. 90-99 10 p. |
artikel |
14 |
Spasmolytic and tonic effect of Iberogast® (STW 5) in intestinal smooth muscle
|
Ammon, H.P.T. |
|
2006 |
13 |
S1 |
p. 67-74 8 p. |
artikel |
15 |
STW 5 (Iberogast®) and its individual herbal components modulate intestinal electrophysiology of mice
|
Sibaev, A. |
|
2006 |
13 |
S1 |
p. 80-89 10 p. |
artikel |
16 |
STW 5 (Iberogast®) reduces afferent sensitivity in the rat small intestine
|
Müller, M.H. |
|
2006 |
13 |
S1 |
p. 100-106 7 p. |
artikel |
17 |
The active components and the pharmacological multi-target principle of STW 5 (Iberogast®)
|
Wegener, T. |
|
2006 |
13 |
S1 |
p. 20-35 16 p. |
artikel |